🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin

Neuro-Oncology(2022)10.1093/neuonc/noac243Source: DataRank Database

Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin is a research paper published in Neuro-Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 1.68)OA: greenTopics (27)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (40)

Junko Murai ORCID,Masayasu Okada ORCID,Haruhiko Takahashi ORCID,Tyler H Findlay,Kristen Malebranche

Live enrichment

PubMed:36273330 OpenAlex:https://openalex.org/W4307114519

Japanese Society for Promotion of Science

Grant: 17K16632

Japanese Society for Promotion of Science

Grant: 19K09476

Japanese Society for Promotion of Science

Grant: 21KK0156

Japanese Society for Promotion of Science

Grant: 22K16679

Japanese Society for Promotion of Science

Grant: 17K17739

Japanese Society for Promotion of Science

Grant: 20K17955

Japanese Society for Promotion of Science

Grant: 19K18418

Japanese Society for Promotion of Science

Grant: JP19H03505

NIH grant

Grant: R01CA255331

National Cancer Institute

Grant: Z01-BC-006150

FWCI

1.68

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

greenLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10158119/pdf/noac243.pdf

BRONZEhttps://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noac243/47465095/noac243.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10158119/pdf/noac243.pdf

publisherhttps://academic.oup.com/neuro-oncology/article-pdf/25/5/899/50196450/noac243.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10158119

Fields of Study

PARP inhibition in cancer therapyGlioma Diagnosis and TreatmentHistone Deacetylase Inhibitors ResearchMedicineBiology

MeSH Terms

IrinotecanCerebellar NeoplasmsCisplatinHumansMedulloblastomaNuclear ProteinsUp-RegulationEpigenesis, GeneticHedgehog Proteins

Keywords

MedulloblastomaCancer researchCisplatinBiologyWnt signaling pathwayHistone deacetylase inhibitorDownregulation and upregulationHistone deacetylaseHistoneChemotherapyDNAGeneGenetics

Sustainable Development Goals

SDG 0: Good health and well-being